Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a new real-world post-marketing surveillance study in Pain Medicine that demonstrates the safety, efficacy and [...]
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS). Full story.
AAPM Foundation President Charles Argoff, MD, and his colleagues at Albany Medical Center invite you to attend the 5th Annual The Art and Science of Pain Management Virtual Conference that will be held on October [...]
This study is intended to monitor outcomes for 1 year following cervical TFESI. Based on current clinic volume and enrollment rates into a current study of cervical epidural injections that is nearing completion, we conservatively [...]
According to a national survey of patients with chronic pain, cost is one of several barriers to accessing multidisciplinary treatment, and many patients would like a wider choice of specialists and therapies. Full story.
Migraine is a severe and debilitating neurologic disorder and is claimed to be the sixth disabling illness in the world. This study aimed to determine the overall prevalence of restless legs syndrome (RLS) in patients [...]
Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved QDOLO™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management [...]
This study will assess the effect of incorporating a tonal exercise device into clinical and chiropractic care for lower back pain. Full story.
Current pharmacologic therapies for patients with osteoarthritis are suboptimal.To determine the efficacy of Curcuma longa extract (CL) for reducing knee symptoms and effusion–synovitis in patients with symptomatic knee osteoarthritis and knee effusion–synovitis. Full story.
A recent study examining pain among cannabis users suggests that—unlike long-term opioid use—regular cannabis use does not appear to increase pain sensitivity. Full story.
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.
